Induction of M-CSF receptor and its mRNA, and activation of tyrosine kinase in peripheral monocytes by oestradiol-17 beta and progesterone.
In monocytes at the secretory (oestrogen-progesterone dominant) phase of the menstrual cycle, expression of c-fms and macrophage colony-stimulating factor (M-CSF) receptor and activity of tyrosine kinase (TK) were increased by oestradiol with or without progesterone. In vivo, oestrogen may induce expression of c-fms and M-CSF receptor as well as the activation of TK in monocytes under the milieu of the secretory phase. Alternatively, cells of monocyte lineage during the secretory phase might, via various factors, obtain the potency to induce the expression and the function of M-CSF receptors, this potency being effected by oestrogen. Macrophages in peritoneal fluid in pelvic endometriosis (oestrogen predominant) might be activated during the secretory phase of the menstrual cycle, causing infertility.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D001483:Base Sequence; D004789:Enzyme Activation; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005453:Fluorescence; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D008954:Models, Biological; D008969:Molecular Sequence Data; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000187:drug effects*; D012333:RNA, Messenger / Q000096:biosynthesis*; D016186:Receptor, Macrophage Colony-Stimulating Factor / Q000096:biosynthesis / Q000235:genetics*
D000995:Antitubercular Agents; D012333:RNA, Messenger; D011374:Progesterone; D004958:Estradiol; D011505:Protein-Tyrosine Kinases; D016186:Receptor, Macrophage Colony-Stimulating Factor